Flomax

Flomax is a brand name of tamsulosin, approved by the FDA in the following formulation(s):

FLOMAX (tamsulosin hydrochloride - capsule; oral)

• 
  Manufacturer: BOEHRINGER INGELHEIM
  
  Approval date: April 15, 1997
  
  Strength(s): 0.4MG ^[RLD][AB]

Has a generic version of Flomax been approved?

A generic version of Flomax has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Flomax and have been approved by the FDA:

tamsulosin hydrochloride capsule; oral

• 
  Manufacturer: IMPAX LABS
  
  Approval date: March 2, 2010
  
  Strength(s): 0.4MG ^[AB]


• 
  Manufacturer: MYLAN
  
  Approval date: April 27, 2010
  
  Strength(s): 0.4MG ^[AB]


• 
  Manufacturer: SANDOZ
  
  Approval date: April 27, 2010
  
  Strength(s): 0.4MG ^[AB]


• 
  Manufacturer: SUN PHARM INDS LTD
  
  Approval date: July 15, 2010
  
  Strength(s): 0.4MG ^[AB]


• 
  Manufacturer: SYNTHON PHARMS
  
  Approval date: April 27, 2010
  
  Strength(s): 0.4MG ^[AB]


• 
  Manufacturer: TEVA PHARMS
  
  Approval date: April 27, 2010
  
  Strength(s): 0.4MG ^[AB]


• 
  Manufacturer: WOCKHARDT
  
  Approval date: April 27, 2010
  
  Strength(s): 0.4MG ^[AB]


• 
  Manufacturer: ZYDUS PHARMS USA INC
  
  Approval date: April 27, 2010
  
  Strength(s): 0.4MG ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Flomax. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Flomax.

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • December 22, 2012 - INFORMATION FROM PEDIATRIC STUDIES ADDED TO LABEL
  
  
  • June 22, 2013 - PEDIATRIC EXCLUSIVITY
  
  

See also...

• Flomax Consumer Information (Drugs.com)
• Flomax Consumer Information (Wolters Kluwer)
• Flomax Consumer Information (Cerner Multum)
• Flomax Advanced Consumer Information (Micromedex)
• Flomax AHFS DI Monographs (ASHP)
• Tamsulosin Consumer Information (Wolters Kluwer)
• Tamsulosin Consumer Information (Cerner Multum)
• Tamsulosin Advanced Consumer Information (Micromedex)
• Tamsulosin Hydrochloride AHFS DI Monographs (ASHP)